Clinical trialNCT04055376Active, not recruitingInterventional

Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease

SponsorMassachusetts Institute of TechnologyEnrollment15Alzheimer DementiaAlzheimer Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

In this trial, the safety and effect of daily exposure to light and sound stimulation on people with mild Alzheimer's Disease (AD) will be studied. COVID-19 Amendment: Due to the ongoing suspension of all in-person humans subject research across MIT in response to the COVID-19 pandemic, all enrolled participants who have not completed their 6-month visit will have their visit postponed to 9 months with a follow up at 18 months. Subjects who have completed their 6-month visit will still be instructed to continue and return at Month 12 for an evaluation. OPTIONAL: If the subject would like to come in for an evaluation between Month 9 and 18, we will invite participants to come on Month 12 to complete cognitive testing and EEG.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Diane Chan, MD, PhD
Massachusetts Institute of Technology
Principal Investigator
clinicaltrials.gov ↗
Edward S Boyden, PhD
Massachusetts Institute of Technology
Principal Investigator
clinicaltrials.gov ↗
Emery Brown, MD, PhD
Massachusetts Institute of Technology
Principal Investigator
clinicaltrials.gov ↗
Li-Huei Tsai, PhD
Massachusetts Institute of Technology
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Massachusetts Institute of Technology
Cambridge, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 Aug 2019
Primary completion: 15 Jan 2027
Completion: 15 Jan 2027
Last update posted: 26 May 2026
Registered enrollment: 15
Registry id: NCT04055376

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.